LKT Labs

Biochemicals for Life Science Research

Toremifene Base

Toremifene Base

Product ID T5769
Cas No. 89778-26-7
Purity ≥98%
Product Unit SizeCostQuantityStock
500 mg $108.50 In stock
1 g $173.60 In stock
5 g $649.40 In stock
Bulk Quote

Quicklinks

Description

Toremifene is a selective estrogen receptor modulator (SERM) that also moderates androgen receptor activity. Ite displays anticancer chemotherapeutic and anti-angiogenic activities. Clinically, this compound is used to treat breast cancer and prostate cancer. Toremifene decreases microvessel density and induces remission of benign fibrous lesions in clinical settings with subjects experiencing desmoid tumors. Additionally, it increases latency to tumor formation, decreases tumor number, and increases survival in animal models of prostate cancer.

Product Info

Cas No.

89778-26-7
Purity

≥98%
Formula

C26H28ClNO
Formula Wt.

405.96
Chemical Name

2-[4-[(1Z)-4-Chloro-1,2-diphenyl-1-butenyl]phenoxy]-N,N-dimethylethanamine
IUPAC Name

2-[4-[(Z)-4-chloro-1,2-diphenylbut-1-enyl]phenoxy]-N, N-dimethylethanamine
Synonym

Toremifene
Melting Point

108-110°C
Appearance

White Crystal Powder

Shipping and Storage

Store Temp

Ambient
Ship Temp

Ambient

Downloads

MSDS

T5769 MSDS PDF
Info Sheet

T5769 Info Sheet PDF

References

Chang BY, Kim SA, Malla B, et al. The Effect of Selective Estrogen Receptor Modulators (SERMs) on the Tamoxifen Resistant Breast Cancer Cells. Toxicol Res. 2011 Jun;27(2):85-93. PMID: 24278556.

Kawashima H, Tanaka T, Cheng JS, et al. Effect of anti-estrogens on the androgen receptor activity and cell proliferation in prostate cancer cells. Urol Res. 2004 Dec;32(6):406-10. PMID: 15316697.

Heidemann J, Ogawa H, Otterson MF, et al. Antiangiogenic treatment of mesenteric desmoid tumors with toremifene and interferon alfa-2b: report of two cases. Dis Colon Rectum. 2004 Jan;47(1):118-22. PMID: 14719159.

Raghow S, Hooshdaran MZ, Katiyar S, et al. Toremifene prevents prostate cancer in the transgenic adenocarcinoma of mouse prostate model. Cancer Res. 2002 Mar 1;62(5):1370-6. PMID: 11888907.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • M0126

    Magainin 2

    Antimicrobial peptide found in frogs, induces p...

    ≥95%
  • R5974

    Rosuvastatin Calcium

    Statin; HMG-CoA reductase inhibitor, potential ...

    ≥98%
  • S1970

    Serum Thymic Factor

    Synthetic peptide hormone.

    ≥95%
  • N3496

    Nizatidine

    Histamine H2 inverse agonist.

    ≥98%
  • S8049

    S-Sulforaphene

    Isothiocyanate found in cruciferous vegetables....

    ≥98%
  • N5770

    Norfloxacin Hydrochloride

    First generation fluoroquinolone antibiotic.

    ≥98%
  • M1650

    Melanotan II

    Synthetis peptide, melanocortin analog; MCR ago...

    ≥98%
  • D564088

    10-Acetyl Docetaxel

    Docetaxel impurity

    ≥98%
  • T7133

    Trimetazidine Dihydrochloride

    Long-chain 3-ketoacyl-CoA thiolase inhibitor, p...

    ≥99%
  • O9702

    Ozagrel Hydrochloride

    TxA2 synthase inhibitor.

    ≥98%
  • B5875

    Bosutinib, structural isomer

    Bosutinib isomer; Src and Abl inhibitor.

    ≥98%
  • D183734

    7-O-Desmethyl Rapamycin

    Rapamycin impurity

    ≥85%
  • N3228

    Nifedipine

    Dihydropyridine; L-type Ca2+ channel blocker.

    ≥98%
  • P0246

    Palomid 529

    mTOR inhibitor.

    ≥98%
  • T3035

    Thienylheptyl Isothiocyanate

    Thienylbutyl ITC analog.

    ≥95%
  • T1953

    Tenovin-3

    Potential p53 activator or SIRT2 inhibitor.

    ≥98%
  • G3557

    Ginsenoside Rh1

    Triterpene saponin found in species of Panax.

    ≥77%
  • S0134

    Saikosaponin D

    Triterpene saponin found in Bupleurum.

    ≥98%
  • G7440

    GSK-1120212

    MEK1/2 inhibitor.

    ≥98%
  • S8344

    R,S-(±)-Sulpiride

    GHB agonist, D2/3 antagonist.

    ≥98%